Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
1 clinical trials · Condition
◉ Watch Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Acalabrutinib Study in Indian Patients With Chronic Lymphocytic Leukaemia & Relapsed and Refractory Mantle Cell Lymphoma (NCT04930536) | AstraZeneca | 2021-07-14 |
Track Chronic Lymphocytic Leukemia and Relapsed and Refractory Mantle Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.